Abstract
Pulmonary fibrosis (PF) can severely disrupt lung function, leading to fatal consequences. Salidroside is a principal active ingredient of Rhodiola rosea and has recently been reported to protect against lung injures. The present study was aimed at exploring its therapeutic effects on PF. Lung fibrotic injuries were induced in SD rats by a single intratracheal instillation of 5 mg/kg bleomycin (BLM). Then, these rats were administrated with 50, 100, or 200 mg/kg salidroside for 28 days. BLM-triggered structure distortion, collagen overproduction, excessive inflammatory infiltration, and pro-inflammatory cytokine release, and oxidative stress damages in lung tissues were attenuated by salidroside in a dose-dependent manner. Furthermore, salidroside was noted to inhibit IκBα phosphorylation and nuclear factor kappa B (NF-κB) p65 nuclear accumulation while activating Nrf2-antioxidant signaling in BLM-treated lungs. Downregulation of E-cadherin and upregulation of vimentin, fibronectin, and α-smooth muscle actin (α-SMA) indicated an epithelial-mesenchymal transition (EMT)-like shift in BLM-treated lungs. These changes were suppressed by salidroside. The expression of TGF-β1 and the phosphorylation of its downstream targets, Smad-2/-3, were enhanced by BLM, but weakened by salidroside. Additionally, salidroside was capable of reversing the recombinant TGF-β1-induced EMT-like changes in alveolar epithelial cells in vitro. Our study reveals that salidroside’s protective effects against fibrotic lung injuries are correlated to its anti-inflammatory, antioxidative, and antifibrotic properties.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abraham V, Chou ML, DeBolt KM, Koval M (1999) Phenotypic control of gap junctional communication by cultured alveolar epithelial cells. Am J Physiol 276:L825–L834
Alvira CM (2014) Nuclear factor-kappa-B signaling in lung development and disease: one pathway, numerous functions. Birth Defects Res A Clin Mol Teratol 100:202–216. doi:10.1002/bdra.23233
Arizmendi N et al (2014) Rac2 is involved in bleomycin-induced lung inflammation leading to pulmonary fibrosis. Respir Res 15:71. doi:10.1186/1465-9921-15-71
Bai Y et al (2014) Production of salidroside in metabolically engineered Escherichia coli. Sci Rep 4:6640. doi:10.1038/srep06640
Balestrini JL, Chaudhry S, Sarrazy V, Koehler A, Hinz B (2012) The mechanical memory of lung myofibroblasts. Integr Biol (Camb) 4:410–421. doi:10.1039/c2ib00149g
Birben E, Sahiner UM, Sackesen C, Erzurum S, Kalayci O (2012) Oxidative stress and antioxidant defense. World Allergy Organ J 5:9–19. doi:10.1097/WOX.0b013e3182439613
Bocchino M et al (2010) Reactive oxygen species are required for maintenance and differentiation of primary lung fibroblasts in idiopathic pulmonary fibrosis. PLoS One 5:e14003. doi:10.1371/journal.pone.0014003
Della Latta V, Cecchettini A, Del Ry S, Morales MA (2015) Bleomycin in the setting of lung fibrosis induction: from biological mechanisms to counteractions. Pharmacol Res 97:122–130. doi:10.1016/j.phrs.2015.04.012
Friedman SL, Sheppard D, Duffield JS, Violette S (2013) Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med 5:167sr161. doi:10.1126/scitranslmed.3004700
Gonzalez DM, Medici D (2014) Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal 7:re8. doi:10.1126/scisignal.2005189
Guan S et al (2012) Protective effects of salidroside from Rhodiola rosea on LPS-induced acute lung injury in mice. Immunopharmacol Immunotoxicol 34:667–672. doi:10.3109/08923973.2011.650175
Hashimoto N et al (2010) Endothelial-mesenchymal transition in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol 43:161–172. doi:10.1165/rcmb.2009-0031OC
Hinz B (2009) Tissue stiffness, latent TGF-beta1 activation, and mechanical signal transduction: implications for the pathogenesis and treatment of fibrosis. Curr Rheumatol Rep 11:120–126
Huang X et al (2015) Salidroside attenuates chronic hypoxia-induced pulmonary hypertension via adenosine A2a receptor related mitochondria-dependent apoptosis pathway. J Mol Cell Cardiol 82:153–166. doi:10.1016/j.yjmcc.2015.03.005
Jiang L et al (2015) Metabolic reprogramming during TGFbeta1-induced epithelial-to-mesenchymal transition. Oncogene 34:3908–3916. doi:10.1038/onc.2014.321
Kikuchi N et al (2010) Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res 11:31. doi:10.1186/1465-9921-11-31
Kim KK et al (2006) Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci U S A 103:13180–13185. doi:10.1073/pnas.0605669103
King TE Jr et al (2014) A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med 370:2083–2092. doi:10.1056/NEJMoa1402582
Lamouille S, Xu J, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 15:178–196. doi:10.1038/nrm3758
Li HB, Chen F (2001) Preparative isolation and purification of salidroside from the Chinese medicinal plant Rhodiola sachalinensis by high-speed counter-current chromatography. J Chromatogr A 932:91–95
Martinez FJ, de Andrade JA, Anstrom KJ, King TE Jr, Raghu G (2014) Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 370:2093–2101. doi:10.1056/NEJMoa1401739
Massague J, Seoane J, Wotton D (2005) Smad transcription factors. Genes Dev 19:2783–2810. doi:10.1101/gad.1350705
Noble PW, Barkauskas CE, Jiang D (2012) Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 122:2756–2762. doi:10.1172/JCI60323
Noth I et al (2012) A placebo-controlled randomized trial of warfarin in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 186:88–95. doi:10.1164/rccm.201202-0314OC
Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, Brown KK (2007) Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. Am J Respir Crit Care Med 176:277–284. doi:10.1164/rccm.200701-044OC
Ouyang J, Gao Z, Ren Z, Hong D, Qiao H, Chen Y (2010) Synergistic effects of rMSCs and salidroside on the experimental hepatic fibrosis. Pharmazie 65:607–613
Papageorgis P et al (2010) Smad signaling is required to maintain epigenetic silencing during breast cancer progression. Cancer Res 70:968–978. doi:10.1158/0008-5472.CAN-09-1872
Qu ZQ, Zhou Y, Zeng YS, Li Y, Chung P (2009) Pretreatment with Rhodiola rosea extract reduces cognitive impairment induced by intracerebroventricular streptozotocin in rats: implication of anti-oxidative and neuroprotective effects. Biomed Environ Sci 22:318–326. doi:10.1016/S0895-3988(09)60062-3
Qu ZQ, Zhou Y, Zeng YS, Lin YK, Li Y, Zhong ZQ, Chan WY (2012) Protective effects of a Rhodiola crenulata extract and salidroside on hippocampal neurogenesis against streptozotocin-induced neural injury in the rat. PLoS One 7:e29641. doi:10.1371/journal.pone.0029641
Raghu G, Million-Rousseau R, Morganti A, Perchenet L, Behr J (2013) Macitentan for the treatment of idiopathic pulmonary fibrosis: the randomised controlled MUSIC trial. Eur Respir J 42:1622–1632. doi:10.1183/09031936.00104612
Richeldi L et al (2014) Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med 370:2071–2082. doi:10.1056/NEJMoa1402584
Shelton P, Jaiswal AK (2013) The transcription factor NF-E2-related factor 2 (Nrf2): a protooncogene? FASEB J 27:414–423. doi:10.1096/fj.12-217257
Tanjore H et al (2009) Contribution of epithelial-derived fibroblasts to bleomycin-induced lung fibrosis. Am J Respir Crit Care Med 180:657–665. doi:10.1164/rccm.200903-0322OC
Teixeira KC et al (2008) Attenuation of bleomycin-induced lung injury and oxidative stress by N-acetylcysteine plus deferoxamine. Pulm Pharmacol Ther 21:309–316. doi:10.1016/j.pupt.2007.07.006
Walters DM, Cho HY, Kleeberger SR (2008) Oxidative stress and antioxidants in the pathogenesis of pulmonary fibrosis: a potential role for Nrf2. Antioxid Redox Signal 10:321–332. doi:10.1089/ars.2007.1901
Wang J, Li JZ, Lu AX, Zhang KF, Li BJ (2014) Anticancer effect of salidroside on A549 lung cancer cells through inhibition of oxidative stress and phospho-p38 expression. Oncol Lett 7:1159–1164. doi:10.3892/ol.2014.1863
White ES, Lazar MH, Thannickal VJ (2003) Pathogenetic mechanisms in usual interstitial pneumonia/idiopathic pulmonary fibrosis. J Pathol 201:343–354. doi:10.1002/path.1446
Wolters PJ, Collard HR, Jones KD (2014) Pathogenesis of idiopathic pulmonary fibrosis. Annu Rev Pathol 9:157–179. doi:10.1146/annurev-pathol-012513-104706
Zhang Z, Ding L, Wu L, Xu L, Zheng L, Huang X (2014) Salidroside alleviates paraquat-induced rat acute lung injury by repressing TGF-beta1 expression. Int J Clin Exp Pathol 7:8841–8847
Zhao HB et al (2014) Salidroside induces neuronal differentiation of mouse mesenchymal stem cells through Notch and BMP signaling pathways. Food Chem Toxicol 71:60–67. doi:10.1016/j.fct.2014.05.031
Zheng K, Sheng Z, Li Y, Lu H (2014) Salidroside inhibits oxygen glucose deprivation (OGD)/re-oxygenation-induced H9c2 cell necrosis through activating of Akt-Nrf2 signaling. Biochem Biophys Res Commun 451:79–85. doi:10.1016/j.bbrc.2014.07.072
Acknowledgments
This study was supported by grants from the National Nature Science Foundation of China (No. 81273924) and the Nature Science Foundation of Liaoning Province (No. 2013023028).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Haiying Tang and Lili Gao contributed equally to this work.
Rights and permissions
About this article
Cite this article
Tang, H., Gao, L., Mao, J. et al. Salidroside protects against bleomycin-induced pulmonary fibrosis: activation of Nrf2-antioxidant signaling, and inhibition of NF-κB and TGF-β1/Smad-2/-3 pathways. Cell Stress and Chaperones 21, 239–249 (2016). https://doi.org/10.1007/s12192-015-0654-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12192-015-0654-4